If Conkwest IPO is hot (I expect it will be), it should benefit SRNE. As part of the Conkwest/SRNE collaboration, SRNE made “a $9 million strategic equity investment in Conkwest.”
Also, the Conkwest S1 states: “Although Sorrento has one of the largest fully human antibody libraries in the world, Sorrento’s antibodies may not be compatible with our taNK product candidates and there may be other libraries that would be more compatible with our technology and would produce better results for us. To the extent that we use antibodies from other parties for our taNK product candidates, we would still be required to pay royalties to Sorrento.”
Market Data 
Markets 
AI
